Valeant Pharmaceuticals International, Inc. (TSE:VRX – Get Free Report) (NYSE:VRX)’s stock price traded down 3.3% on Monday . The company traded as low as C$30.75 and last traded at C$30.80. 1,232,408 shares traded hands during trading, a decline of 11% from the average session volume of 1,382,994 shares. The stock had previously closed at C$31.86.
Valeant Pharmaceuticals International Stock Performance
The firm’s 50-day moving average price is C$30.80.
Valeant Pharmaceuticals International Company Profile
Valeant Pharmaceuticals International, Inc operates as a multinational, specialty pharmaceutical, and medical device company that develops, manufactures, and markets a range of pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company operates through three segments: Bausch + Lomb/International, Branded Rx, and U.S.
Further Reading
- Five stocks we like better than Valeant Pharmaceuticals International
- 3 Warren Buffett Stocks to Buy Now
- The Charles Schwab Company Can Hit New Highs
- What is Insider Trading? What You Can Learn from Insider Trading
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- Overbought Stocks Explained: Should You Trade Them?
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Valeant Pharmaceuticals International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeant Pharmaceuticals International and related companies with MarketBeat.com's FREE daily email newsletter.
